Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Vaibhav Mundra
Institution:
All India Institute of Medical Sciences Jodhpur
Observed institutions:
University of Tennessee Health Science Center,
All India Institute of Medical Sciences Jodhpur,
University of Manchester,
BeiGene (China),
BeOne Medicines (Switzerland),
University of Nebraska Medical Center,
Manchester University
show all 7
ORCID:
0000-0002-7835-2570
Observed ORCID:
0000-0002-7835-2570
OpenAlex ID:
A5058524250
Mesenchymal Stem Cell-Based Therapy
2012
·
Vaibhav Mundra
, Ivan C. Gerling
, et al.
·
Molecular Pharmaceutics
·
143
Nanoparticle-Mediated Drug Delivery for Treating Melanoma
2015
·
Vaibhav Mundra
, Wei Li
, et al.
·
Nanomedicine
·
68
Pharmacokinetics and biodistribution of polymeric micelles containing miRNA and small-molecule drug in orthotopic pancreatic tumor-bearing mice
2018
·
Virender Kumar
, Vaibhav Mundra
, et al.
·
Theranostics
·
63
Micellar formulation of indocyanine green for phototherapy of melanoma
2015
·
Vaibhav Mundra
, Yang Peng
, et al.
·
Journal of Controlled Release
·
61
Nanomedicines of Hedgehog Inhibitor and PPAR-γ Agonist for Treating Liver Fibrosis
2013
·
Virender Kumar
, Vaibhav Mundra
, et al.
·
Pharmaceutical Research
·
48
Attenuation of early liver fibrosis by pharmacological inhibition of smoothened receptor signaling
2012
·
Akshay Pratap
, Saurabh Singh
, et al.
·
Journal of drug targeting
·
43
Design of nanocarriers for efficient cellular uptake and endosomal release of small molecule and nucleic acid drugs: learning from virus
2014
·
Vaibhav Mundra
, Ram I. Mahato
·
Frontiers of Chemical Science and Engineering
·
27
Formulation and Characterization of Polyester/Polycarbonate Nanoparticles for Delivery of a Novel Microtubule Destabilizing Agent
2012
·
Vaibhav Mundra
, Yan Lu
, et al.
·
Pharmaceutical Research
·
25
Systemic delivery of nanoparticle formulation of novel tubulin inhibitor for treating metastatic melanoma
2015
·
Vaibhav Mundra
, Yang Peng
, et al.
·
Drug Delivery and Translational Research
·
18
Genetically Modified Human Bone Marrow Derived Mesenchymal Stem Cells for Improving the Outcome of Human Islet Transplantation
2013
·
Vaibhav Mundra
, Hao Wu
, et al.
·
PLoS ONE
·
17
PDF
Polymer conjugate of a microtubule destabilizer inhibits lung metastatic melanoma
2017
·
Ruinan Yang
, Goutam Mondal
, et al.
·
Journal of Controlled Release
·
12
A phase 1, open-label, randomized drug–drug interaction study of zanubrutinib with moderate or strong CYP3A inhibitors in patients with B-cell malignancies
2022
·
Bilal Tariq
, Ying C. Ou
, et al.
·
Leukemia & lymphoma/Leukemia and lymphoma
·
8
Preliminary Safety of a Bcl-2 Inhibitor, Bgb-11417, in Patients with Relapsed/Refractory Multiple Myeloma Harboring t(11,14): A Non-Randomized, Open-Label, Phase 1b/2 Study
2022
·
Hang Quach
, Rajeev Rajagopal
, et al.
·
Blood
·
5
Relative Bioavailability, Food Effect, and Bioequivalence Studies to Assess a New Zanubrutinib 160‐mg Tablet: Results From 2 Phase 1 Studies in Healthy Volunteers
2025
·
Bilal Tariq
, Chester Lin
, et al.
·
Clinical Pharmacology in Drug Development
·
1
PDF
Methods to Separate, Characterize, and Encapsulate Drug Molecules into Exosomes for Targeted Delivery and Treatment of Glioblastoma
2020
·
Yen Nguyen
, Sandeep Kaur
, et al.
·
Neuromethods
·
1
Tiny Particles, Major Risks: An Integrative Review of Micro- and Nanoplastics Exposure and Its Medical Significance
2026
·
Rohit Sharma
, Pravesh Agrawal
, et al.
·
International Journal of Pharmaceutical Sciences Review and Research
PDF
Polymeric Nanocarriers for Treatment of Melanoma and Genetically Modified Mesenchymal Stem Cells to Improve Outcome of Islet Transplantation
2015
·
Vaibhav Mundra
·
DigitalCommons@UNMC
PDF
Show more works
View as search
Works count:
17
Citation count:
540
H-index:
11
I10-index:
11
Year
Topic
Type